| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 09/02/2009 | EP2094656A2 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 09/02/2009 | EP1828120A4 Improved process for the preparation of (s)-alpha-etyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
| 09/02/2009 | EP1794129A4 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | CN100534990C Pyrrolidone carboxamides |
| 09/01/2009 | US7582782 Organic compounds |
| 09/01/2009 | US7582774 reacting hydroxyamine with succinic anhydride, or succinic acid to produce N-hydroxysuccinimide; using solvent undergoing azeotropy with water while carrying out dewatering; oxidizing agents for use photography developers, reagents for synthetically preparing peptides; intermediates for insecticides |
| 09/01/2009 | US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 09/01/2009 | US7582755 Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | US7582658 Bicyclic compound |
| 09/01/2009 | US7582656 Guanidine derivatives and therapeutic uses thereof |
| 09/01/2009 | US7582124 Hair dyeing composition |
| 09/01/2009 | CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them |
| 09/01/2009 | CA2491133C Process for the preparation of amino-pyrrolidine derivatives |
| 09/01/2009 | CA2256941C Process for the alkylation of alkyl- or benzylcyanogen derivatives in the presence of trialkylamines or -phosphines |
| 08/27/2009 | WO2009105715A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009104557A1 Process for production of n-(3-pyrrolidinyl)glycine derivative |
| 08/27/2009 | WO2009103218A1 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof |
| 08/27/2009 | WO2009084827A3 Synthetic intermediates, process for preparing pyrrolylheptanoic acid derivatives therefrom |
| 08/27/2009 | WO2009026248A3 Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase |
| 08/27/2009 | WO2007079003A3 Amide inhibitors of leukotriene a4 hydrolase |
| 08/27/2009 | US20090216037 Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof |
| 08/27/2009 | US20090216029 Process for the production of atorvastatin calcium in amorphous form |
| 08/27/2009 | US20090215988 Soluble, Degradable Poly(Ethylene Glycol) Derivatives for Controllable Release of Bound Molecules into Solution |
| 08/27/2009 | US20090215857 Therapeutic Pyrrolidines |
| 08/27/2009 | US20090215856 Methods for monitoring IL-18 |
| 08/27/2009 | US20090215855 New Crystalline Atorvastatin Hemicalcium Salt Polymorph Form |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | CA2714703A1 Compounds and compositions as modulators of gpr119 activity |
| 08/26/2009 | EP2091531A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | CN101516867A Aryl sulfonamides with an analgesic action |
| 08/26/2009 | CN101516843A Method for producing succinimide compound |
| 08/26/2009 | CN101516842A A crystalline form B4 of atorvastatin magnesium and a process thereof |
| 08/26/2009 | CN101516835A Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 08/26/2009 | CN101516834A Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 08/26/2009 | CN101516365A Inhibitors of undecaprenyl pyrophosphate synthase |
| 08/26/2009 | CN101514178A Method for synthesizing N-methylpyrrolidone |
| 08/26/2009 | CN101513402A Antiviral agent |
| 08/26/2009 | CN100533145C Array compring structural unit and artificial receptors and its preparation method and structural unit |
| 08/26/2009 | CN100531732C Thiomolybdate analogues |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579379 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 08/25/2009 | US7579369 CB 1 receptor inverse agonists |
| 08/25/2009 | US7579352 Retinoic acid mimetic anilides |
| 08/25/2009 | CA2405172C Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 08/20/2009 | WO2009074733A3 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same |
| 08/20/2009 | US20090209612 Process for the preparation of atorvastatin |
| 08/20/2009 | US20090209588 Novel compounds, their preparation and use |
| 08/20/2009 | US20090209585 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 08/20/2009 | US20090209584 Antibacterial mutilins |
| 08/20/2009 | US20090209514 Tetrahydro-Naphthalene Derivatives as Vanilloid Receptor Antagonists |
| 08/20/2009 | US20090209491 Lactams as conformationally constrained peptidomimetic inhibitors |
| 08/20/2009 | US20090208410 Ed-b fibronectin as stratification marker for anti-tumor drugs |
| 08/19/2009 | EP2089417A2 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 08/19/2009 | EP2089359A2 Mapk/erk kinase inhibitors |
| 08/19/2009 | EP1513802B1 Alpha-sulfonylamino-acetonitriles |
| 08/19/2009 | CN101511822A Modulators of chemokine receptor activity, crystalline forms and process |
| 08/19/2009 | CN101511787A Substituted N-phenylmethyl -5-oxo-proline-2-amides as P2X7-receptor antagonists and their methods of use |
| 08/19/2009 | CN101511786A Process for the preparation of levetiracetam |
| 08/19/2009 | CN101511785A Substituted benzyl amine compounds |
| 08/19/2009 | CN101511783A N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 08/19/2009 | CN101508667A Purification method of N-methyl pyrrolidone |
| 08/19/2009 | CN100529097C Enzymatic synthesis of enatiopure intermediates by means of cholesterolesterase from yeasts |
| 08/19/2009 | CN100528164C Statin therapy for enhancing cognitive maintenance |
| 08/18/2009 | US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide |
| 08/18/2009 | US7576161 contacting a olefin monomer (isobutylene) with an initiator( 2-chloro-2,4,4,-trimethylpentane) in the presence of a Lewis acid and solvent under suitable quasiliving polymerization reaction conditions, contacting quasiliving carbocationically terminated polymer with a pyrrole compound as quenching agent |
| 08/18/2009 | US7576131 Administering 2-acetamidoethyl 4-chlorophenyl-(3-trifluoro-methylphenoxy)acetate, as antidiabetic agents |
| 08/18/2009 | US7576121 Antidiabetic agenst |
| 08/18/2009 | US7576117 Cyclic amine CCR3 antagonist |
| 08/18/2009 | US7576102 Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammation |
| 08/18/2009 | CA2400268C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 08/13/2009 | WO2009100245A1 Low dose hmg-coa reductase inhibitor with reduced side effects |
| 08/13/2009 | WO2009100155A1 Compounds and methods for rapid labeling of n-glycans |
| 08/13/2009 | WO2009100095A1 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity |
| 08/13/2009 | WO2009099080A1 Novel phenylpyrrole derivative |
| 08/13/2009 | WO2009098458A2 Difluorobiphenylamide derivatives for the treatment of ocular hypertension |
| 08/13/2009 | WO2009097992A1 Insecticidal arylpyrrolines |
| 08/13/2009 | WO2009053446A3 Pregabalin intermediates and process for preparing them and pregabalin |
| 08/13/2009 | WO2009019534A3 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 08/13/2009 | US20090203860 Nonpolar phase-soluble methathesis catalysts |
| 08/13/2009 | US20090203763 Substituted benzhydrylethers |
| 08/13/2009 | US20090203739 Anti-Inflammatory Agents |
| 08/13/2009 | US20090203706 Lysine-based polymeric linkers |
| 08/13/2009 | US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics |
| 08/13/2009 | CA2715143A1 Novel phenylpyrrole derivative |
| 08/13/2009 | CA2714398A1 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity |
| 08/13/2009 | CA2714033A1 Insecticidal arylpyrrolines |
| 08/13/2009 | CA2713547A1 Biaryl amides |
| 08/12/2009 | EP2086924A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation |
| 08/12/2009 | EP2086327A1 Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents |
| 08/12/2009 | EP1863871B1 Rubber composition comprising an itaconimido-maleimide |
| 08/12/2009 | EP1429771B1 Bicyclic compounds as inhibitors of chemokine binding to us28 |
| 08/12/2009 | EP1392328B1 Medicament for protection in radiotherapy |
| 08/12/2009 | EP1077941B1 Compounds with growth hormone releasing properties |
| 08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
| 08/12/2009 | CN101506157A Co-crystals of pyrrolidinones |
| 08/12/2009 | CN101506156A Pyrrolidine derivatives having activity at the GlyT1 transporter |